Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Regul Toxicol Pharmacol ; 128: 105088, 2022 Feb.
Article in English | MEDLINE | ID: mdl-34838871

ABSTRACT

The whole or ground seeds of the food ingredient Nigella sativa L., known in Western culture as "black cumin" or "black caraway", has a three-millennial history of use in Middle- and Far-Eastern cultures as a food ingredient. The seed and its extracts have also been increasingly reported as a successful therapeutic agent with efficacy often attributed to the presence of the powerful antioxidant, thymoquinone. However, quantitative analysis of the seed (especially the volatile fraction) yields widely variable results, which may be due to one or a combination of different crop origins or possible varietal differences, contamination/adulteration, method of extraction, stage of maturation of the extracted seed and other factors. Nonetheless, despite the reported wide variability in bioactive constituents, many publications cite quantifiable outcomes in in vitro and in vivo toxicity testing and in clinical trials. There are a few reports describing allergic reactions in humans when N. sativa extracts are applied to the skin. Notwithstanding the foregoing, N. sativa seeds, used as a food ingredient at historical levels of consumption and as traditionally practiced are safe and Generally Recognized As Safe.


Subject(s)
Food Ingredients/toxicity , Nigella sativa/toxicity , Animals , Dermatitis, Contact/etiology , Dose-Response Relationship, Drug , Humans , Mice , Nigella sativa/chemistry , Nigella sativa/classification , Nigella sativa/growth & development , Oils, Volatile/administration & dosage , Plant Extracts/pharmacology , Plants, Medicinal/chemistry , Plants, Medicinal/classification , Plants, Medicinal/toxicity , Rats , Seeds , Spices , United States , United States Food and Drug Administration/standards
2.
Plant Foods Hum Nutr ; 67(2): 111-9, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22477645

ABSTRACT

Obesity is closely associated with increased incidence of cardiovascular diseases, cancer, insulin resistance, and immune dysfunction, and thus obesity-mitigation strategies should take into account these secondary pathologies in addition to promoting weight loss. Recent studies indicate that black cumin (Nigella sativa) has cardio-protective, anti-cancer, anti-diabetic, antioxidant, and immune-modulatory properties. While black cumin and/or its major bioactive constituent, thymoquinone have demonstrated bioactivity in a variety of disease models, the mechanisms of action are largely unknown. Given the growing interest in and the use of functional foods and nutraceuticals, as well as the increase in obesity and chronic diseases worldwide, further research into the therapeutic/preventive effects of black cumin may be beneficial.


Subject(s)
Benzoquinones/pharmacology , Nigella sativa/chemistry , Obesity/drug therapy , Plant Extracts/pharmacology , Antioxidants/pharmacology , Cardiovascular Diseases/complications , Cardiovascular Diseases/prevention & control , Chemoradiotherapy, Adjuvant/methods , Humans , Insulin Resistance , Neoplasms/complications , Neoplasms/prevention & control , Nigella sativa/toxicity , Obesity/complications , Weight Loss
SELECTION OF CITATIONS
SEARCH DETAIL
...